Thermo Fisher CDR (Cad Hedged) (TMO.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 2,325,000 | 2,277,000 | 2,267,000 | 2,033,000 | 1,758,000 |
| Income taxes - deferred | -552,000 | -302,000 | -379,000 | -1,098,000 | -620,000 |
| Accounts receivable | -1,302,000 | -225,000 | -366,000 | -362,000 | -352,200 |
| Accounts payable and accrued liabilities | 59,000 | 266,000 | 201,000 | 274,000 | 55,500 |
| Other Working Capital | -299,000 | -615,000 | -477,000 | 694,000 | -184,100 |
| Other Operating Activity | 8,058,000 | 3,572,000 | 3,297,000 | 2,464,000 | 2,499,100 |
| Operating Cash Flow | $8,289,000 | $4,973,000 | $4,543,000 | $4,005,000 | $3,156,300 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,466,000 | -890,000 | -708,000 | -501,000 | -418,100 |
| Net Acquisitions | -38,000 | -715,000 | -536,000 | -7,226,000 | -5,188,400 |
| Sale Of Investment | N/A | N/A | N/A | 22,000 | 81,200 |
| Other Investing Activity | -6,000 | 118,000 | -9,000 | -24,000 | -6,800 |
| Investing Cash Flow | $-1,510,000 | $-1,487,000 | $-1,253,000 | $-7,729,000 | $-5,532,100 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -4,000 | -683,000 | -194,000 | -134,000 | 904,100 |
| Debt Issued | 3,464,000 | 5,638,000 | 690,000 | 6,459,000 | 7,604,000 |
| Debt Repayment | -713,000 | -6,360,000 | -2,052,000 | -3,299,000 | -4,334,200 |
| Common Stock Issued | N/A | 0 | 0 | 1,690,000 | 0 |
| Common Stock Repurchased | -1,500,000 | -1,500,000 | -500,000 | -750,000 | -1,250,000 |
| Dividend Paid | -337,000 | -297,000 | -266,000 | -237,000 | -238,400 |
| Other Financing Activity | 49,000 | 84,000 | 85,000 | 125,000 | 175,100 |
| Financing Cash Flow | $959,000 | $-3,118,000 | $-2,237,000 | $3,854,000 | $2,860,600 |
| Exchange Rate Effect | 176,000 | -63,000 | -297,000 | 420,000 | -150,700 |
| Beginning Cash Position | 2,422,000 | 2,117,000 | 1,361,000 | 811,000 | 452,100 |
| End Cash Position | 10,336,000 | 2,422,000 | 2,117,000 | 1,361,000 | 786,200 |
| Net Cash Flow | $7,738,000 | $368,000 | $1,053,000 | $130,000 | $484,800 |
| Free Cash Flow | |||||
| Operating Cash Flow | 8,289,000 | 4,973,000 | 4,543,000 | 4,005,000 | 3,156,300 |
| Capital Expenditure | -1,474,000 | -926,000 | -758,000 | -508,000 | -444,400 |
| Free Cash Flow | 6,815,000 | 4,047,000 | 3,785,000 | 3,497,000 | 2,711,900 |